CVRdatabase
Menu

Scantox Ballerup ApS

Private limited companyCVR 34724938BallerupActive

Scantox Ballerup ApS is a private limited company, based in Ballerup, active in research and experimental development on natural sciences and engineering, founded in 2012. Equity was negative at the end of 2025 (−DKK 1.5m). The company went from a profit in 2024 to a loss of DKK 1.9m in 2025. Gross profit is higher than that of 84% of the companies in the industry in the database.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 13.3m−28.7% vs. 2024
Net profit−DKK 1.9m−857.2% vs. 2024
Equity−DKK 1.5m−493.3% vs. 2024
Employees14latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit fell 29% (2024 → 2025), to DKK 13.3m.
  • Net profit went from a profit of DKK 255k to a loss of DKK 1.9m (2024 → 2025).
  • Equity turned negative: −DKK 1.5m (2024 → 2025).

Employees

  • 5 fewer employees than a year earlier: 14 (08/2026) against 19 (08/2025).

Management and owners, last 24 months

  • New in management: Helle Kirstein Erichsen (director, 01/12/2025) and Emil Staal Bergander (board member, 21/09/2026).
  • Stepped down: Ann Vivian Fullerton (director, 01/12/2025) and Martin Amtoft-Christensen (board member, 21/09/2026).

Registrations, last 24 months

  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
  • 28/10/2024: Name changed from SOLURAL PHARMA ApS to Scantox Ballerup ApS

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2018–2025 · amounts in DKK thousand

Equity and net profit

−DKK 2m−DKK 1mDKK 0DKK 1mDKK 2mDKK 3mDKK 4mDKK 5m2018201920242025
EquityNet profit
Financial figures for Scantox Ballerup ApS
2018201920242025Change
Revenuenot statednot statednot statednot stated–
Gross profit4,8806,65818,71613,349−28.7%
Operating profit (EBIT)−2281,335622––
Profit before tax−2501,140324––
Net profit−195830255−1,931−857.2%
Total assets7,0166,64912,1754,929−59.5%
Equity4,1424,822391−1,539−493.3%
Liabilities2,8731,82511,7846,469−45.1%
Cash and cash equivalents5,0084,224165––
Average number of employees772018−10%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2018, 2019, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures. The register has no financial statements for 2020, 2021, 2022, 2023 (changed financial year or not filed).

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 10mDKK 20mDKK 30mDKK 40mDKK 50mDKK 60mDKK 70m2018201920242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Negative equity

    Equity was −DKK 1.5m at the end of 2025.

    How is this calculated?

    Equity in the latest annual report is below zero.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

4 financial years
Annual reports for Scantox Ballerup ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202529/05/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202428/04/2025The companyPDFXBRL
201901/01/2019 – 31/12/201925/03/2020The companyPDFXBRL
201801/01/2018 – 31/12/201815/05/2019The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
051015202509/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profitDKK 13.3mNo. 68 of 421
Better than 84% of the companies in the industry
Equity−DKK 1.5mNo. 354 of 431
Better than 18% of the companies in the industry
Number of employees14No. 98 of 431
Better than 77% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bnHere
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 2,948of 69,742
Better than 96%
No. 67,879of 69,964
Better than 3%
Same industry and fewer than 20 employees329 companies in the comparison
No. 15of 323
Better than 96%
No. 264of 329
Better than 20%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 3,201of 33,588
Better than 90%
No. 32,288of 33,687
Better than 4%
All companies of type ApS66,508 companies in the comparison
No. 4,201of 66,379
Better than 94%
No. 64,407of 66,505
Better than 3%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Scantox Ballerup ApSDKK 13.3m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Scantox Ballerup ApS−DKK 1.9m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Scantox Ballerup ApS−DKK 1.5m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Scantox Ballerup ApS14
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
Scantox Ballerup ApS

Management

3 active registrations

Executive management

Executive management at Scantox Ballerup ApS
NameRoleAppointed
Helle Kirstein ErichsenDirector01/12/2025

Board of directors

Board of directors at Scantox Ballerup ApS
NameRoleAppointed
Jeanet Løgsted NielsenChair of the board20/11/2023
Emil Staal BerganderBoard member21/09/2026
Founders
Ann Vivian Fullerton, Peter Gudmund Nielsen
Former management (5)
Former management at Scantox Ballerup ApS
NameRoleAppointedResigned
Ann Vivian FullertonDirector23/10/201219/11/2023
Peter Gudmund NielsenCEO23/10/201220/11/2023
Bent HøjgaardDirector19/03/201420/11/2023
Ann Vivian FullertonDirector20/11/202301/12/2025
Martin Amtoft-ChristensenBoard member20/11/202321/09/2026

Signing rule: Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem eller af to bestyrelsesmedlemmer i forening

Address and production units

1 active production units

Energivej 42
2750 Ballerup

Ballerup Municipality · Postcode 2750

Production units
Production unitAddressEmployeesP number
Scantox Ballerup ApSEnergivej 42, 2750 Ballerup141018013998

Purpose

Selskabets formål er udvikling, produktion af produkter til medicinalindustrien samt dertil ligeartet virksomhed

The purpose is quoted from the register in Danish.

Changes year by year

31 registered events
20263 changesmanagement 2 · accounts 1
  • Emil Staal Bergander appointed board member
  • Martin Amtoft-Christensen stepped down as board member
  • Annual report for 2025 published
20254 changesmanagement 2 · accounts 1 · industry 1
  • Helle Kirstein Erichsen appointed director
  • Ann Vivian Fullerton stepped down as director
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20242 changesname 1 · industry 1
  • Name changed from SOLURAL PHARMA ApS to Scantox Ballerup ApS
  • Industry changed to Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721900)
202310 changesmanagement 6 · ownership 4
  • Martin Amtoft-Christensen appointed board member
  • Ann Vivian Fullerton appointed director
  • Jeanet Løgsted Nielsen appointed chair of the board
  • Bent Højgaard stepped down as director
  • Peter Gudmund Nielsen stepped down as ceo
  • Scantox Denmark ApS registered as owner (100%)
  • Alvina Holding ApS is no longer registered as owner
  • Helida Holding ApS is no longer registered as owner
  • Cacaam Holding ApS is no longer registered as owner
  • Ann Vivian Fullerton stepped down as director
20201 changeaccounts 1
  • Annual report for 2019 published
20191 changeaccounts 1
  • Annual report for 2018 published
20164 changesownership 4
  • Alvina Holding ApS registered as owner (25%)
  • Helida Holding ApS registered as owner (33.33%)
  • Cacaam Holding ApS registered as owner (25%)
  • Solural Holding ApS is no longer registered as owner
20151 changeownership 1
  • Solural Holding ApS registered as owner (100%)
20142 changesaddress 1 · management 1
  • Moved to Energivej 42, 2750 Ballerup
  • Bent Højgaard appointed director
20123 changesfounded 1 · management 2
  • Registered as SOLURAL PHARMA ApS
  • Peter Gudmund Nielsen appointed ceo
  • Ann Vivian Fullerton appointed director

Related companies

Same industry in Ballerup

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction